Budesonide - CAS# 51333-22-3 llylestrenol CO-1686 potently and selectively inhibits

CO-1686 potently and selectively inhibits growth of NSCLC cells expressing mutant EGFR and induces apoptosis

CBB1007 trihydrochloride is a cell-permeable amidino-guanidinium compound that acts as a potent

InChiKey: HRDUUSCYRPOMSO-ROUUACIJSA-N

PubMed Central PMCID: PMC4449883

Budesonide - CAS# 51333-22-3 llylestrenol CO-1686 potently and selectively inhibitsBudesonide is a glucocorticoid steroid for the treatment of asthma, non infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. Additionally, it is used for Crohn's disease (inflammatory bowel disease). It is marketed by AstraZeneca as a nasal inhalant under the brand name Rhinocort (in Denmark, as Rhinosol), as an oral inhalant under the brand name Pulmicort (in Israel, Budicort), and as